For Health Plans
Better metabolic health outcomes at scale
Our Digital Twin™ technology and clinical care team work together to prevent and improve chronic conditions like type 2 diabetes while reducing health plan costs.
73%
eliminated medications
(including injections)
-2.2
point drop in A1C
Avg among baseline A1C 8.0+
66%
66% improved hypertension
-14 lbs
lost in 6 months
Avg among BMI 30+
81%
improved cholesterol
67%
reduced visceral fat
Twin’s commercial population, members 365+ days in program. Data as of September 2024.
Meet your
Digital Twin™
The Digital Twin™ shows a member’s metabolism in real-time using data from smart devices to help them make informed choices in their daily life.
Walking reduced your glucose levels by 20 points
Keep getting active after meals to reduce spikes and help your body use fuel as energy.
Validated by clinical research
89% reduced A1C below 7 after one year
Distribution of HbA1C levels after one year among DT Intervention participants*. Abbreviations: DT - digital twin; HbA1C - hemoglobin A1C
Shamanna P, Erukulapati RS, Shukla A, Shah L, Willis B, Thajudeen M, Kovil R, Baxi R, Wali M, Damodharan S, Joshi S. One-year outcomes of a digital twin intervention for type 2 diabetes: a retrospective real-world study. Scientific Reports. 2024 Oct 26;14(1):25478.
Twin members continue losing weight after stopping GLP-1s
Twin members2
continue to lose ~6% of body weight on average
Patients without Twin
gain back ~13%
1. Based on the semaglutide (Ozempic) clinical trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542252/#dom14725-supitem-0001) N=228
2. Inclusive of Active Commercial Members >=52 weeks in the Twin T2D Program who stopped GLP-1 >=52 weeks prior to the analysis and had a start BMI >=27
Validated by clinical research
We stand behind our solutions
We’re so confident in the efficacy of our programs that our metabolic health benefits are offered fully at-risk. These programs are based upon the highest quality RCT research, which has been peer-reviewed and published in leading journals.
*Outcomes from a Twin self-insured employer partner
19%
Eligible population activated
within the first year
$8.4k
Annual savings per member
with at least one high-cost medication
$3.2M
Projected pharmacy savings
annualized across all members with 1 or more high-cost meds*
Results that speak for themselves
77%
Members improved insulin resistance (HOMA2IR)
Among T2D members
67%
% Members improved visceral fat
70%
% Members improved inflammation
Among baseline hsCRP >3
83%
% Members A1C no longer uncontrolled
Avg among baseline A1C 9.0+
-2.2
A1C reduction
Avg among baseline A1C 8.0+
-1.1
A1C reduction
Avg among baseline A1C
-17 lbs
Weight loss achieved
Avg among BMI 40+
-14 lbs
Weight loss achieved
Avg among BMI 30+
75%
% Members lost weight
73%
1+ High cost medications eliminated
49%
GLP-1 Prescriptions eliminated
82%
SGLT2 Prescriptions eliminated
66%
% Members improved hypertension
81%
% Members improved cholesterol
Among TG/HDL >=4
77%
% Members improved framingham risk score
Among FRS 20+
69%
% Members improved fatty liver (MAFLD)
86%
% Members improved kidney function (eGFR)
Among Prediabetes and/or Obesity members, eGFR >90
65%
% Members improved kidney function (eGFR)
Among all members eGFR >90
Trusted by leading companies
.png)
Transform employee health with proven results
See how Twin Health’s evidence-based, outcomes-driven programs empower your workforce to thrive—all with a risk-free, performance-based model. Contact us today to learn more.
